NDAQ:ATXI - Post Discussion
Post by
whytestocks on Apr 29, 2024 5:30pm
Avenue Therapeutics Announces Exercise of Warrants for $4.4
Breaking News: $ATXI Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross ProceedsMIAMI, April 29, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced th...
ATXI - Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Be the first to comment on this post